Joyce Wilson leads the team of virologists and geneticists searching for antiviral drugs we can repurpose to stop COVID-19 infections from spreading.

Using a $449,000 grant from the Canadian Institutes of Health Research, Wilson and her team use genomic tools to identify pathways the virus uses as it hijacks cells in the human body. As she tells host Jen Quesnel, from there her team will narrow down antiviral therapeutics that slow or inhibit COVID-19 infections.